Mark D. Goldberg

Family Medicine
5252 E Main St
Mesa, AZ 85205

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

A distinctive form of immune thrombocytopenia in a phase 2 study of alemtuzumab for the treatment of relapsing-remitting multiple sclerosis.

A distinctive form of immune thrombocytopenia in a phase 2 study of alemtuzumab for the treatment of relapsing-remitting multiple sclerosis.

Journal: Blood
Published: October 01, 2011
Showing 1-1 of 1

Last Updated: 09/26/2026